Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 499 entries
View as:

Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities

Phase: N/A Priority: Normal
NCT ID: NCT04982900 Org: User:
Start: 10/01/21 End: 08/01/22 Due: 08/01/23

Endocytoscopy of Upper Gastrointestinal Tract in Acute Graft-versus-host Disease: a Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT06247891 Org: User:
Start: 08/01/21 End: 11/30/23 Due: 11/30/24

Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty

Phase: N/A Priority: Normal
NCT ID: NCT02920515 Org: User:
Start: 09/30/12 End: 08/31/15 Due: 08/31/16

Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Relapsed and Refractory Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03468153 Org: User:
Start: 01/01/18 End: 01/01/20 Due: 01/01/21

Yi Jin Jing Tiger Roaring Speech Rehabilitation With Real-Time Feedback Technique for PD

Phase: N/A Priority: Normal
NCT ID: NCT04528147 Org: User:
Start: 10/01/20 End: 09/30/23 Due: 09/30/24

Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05602415 Org: User:
Start: 11/30/22 End: 05/31/24 Due: 05/31/25

Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04527861 Org: User:
Start: 04/08/21 End: 04/30/29 Due: 04/30/30

Risk Evaluation and Management in Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT02998788 Org: User:
Start: 06/30/16 End: 12/31/26 Due: 12/31/27

Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06404697 Org: User:
Start: 05/31/24 End: 04/30/30 Due: 04/30/31

Risk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - IV

Phase: N/A Priority: Normal
NCT ID: NCT06793787 Org: User:
Start: 07/01/24 End: 12/31/27 Due: 12/31/28

Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts

Phase: N/A Priority: Normal
NCT ID: NCT04310995 Org: User:
Start: 06/02/20 End: 06/28/23 Due: 06/28/24

The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT06644287 Org: User:
Start: 10/15/24 End: 07/31/27 Due: 07/31/28

Stroke and Carotid-Cerebral Vascular Disease After CABG

Phase: N/A Priority: Normal
NCT ID: NCT05036044 Org: User:
Start: 09/04/21 End: 05/31/23 Due: 05/31/24

Safety and Efficacy of IMPT or IMRT for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06826885 Org: User:
Start: 12/01/24 End: 11/30/29 Due: 11/30/30

Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)

Phase: N/A Priority: Normal
NCT ID: NCT05934864 Org: User:
Start: 07/13/23 End: 06/01/26 Due: 06/01/27

Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT06708130 Org: User:
Start: 05/01/21 End: 12/31/31 Due: 12/31/32

Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDS

Phase: N/A Priority: Normal
NCT ID: NCT06247917 Org: User:
Start: 03/03/24 End: 12/31/24 Due: 12/31/25

CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors

Phase: N/A Priority: Normal
NCT ID: NCT06365671 Org: User:
Start: 04/16/24 End: 04/30/27 Due: 04/30/28

SUNDYS: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel-group Trial

Phase: N/A Priority: Normal
NCT ID: NCT04650958 Org: User:
Start: 01/01/21 End: 01/01/22 Due: 01/01/23

Albumin Infusion in Inpatients With Decompensated Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT05719051 Org: User:
Start: 02/01/23 End: 12/31/24 Due: 12/31/25

Risk Evaluation by COronary CTA and Artificial IntelliGence Based fuNctIonal analyZing tEchniques - II

Phase: N/A Priority: Normal
NCT ID: NCT05856110 Org: User:
Start: 07/03/23 End: 12/31/25 Due: 12/31/26

DACAB Trial: Follow-up Extension

Phase: N/A Priority: Normal
NCT ID: NCT03987373 Org: User:
Start: 08/01/19 End: 06/15/21 Due: 06/15/22

Autologous Transplantation of Bronchial Basal Cells for Treatment of COPD

Phase: N/A Priority: Normal
NCT ID: NCT03655795 Org: User:
Start: 11/30/18 End: 03/31/21 Due: 03/31/22

Zanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial Remission

Phase: N/A Priority: Normal
NCT ID: NCT06669143 Org: User:
Start: 11/30/24 End: 12/31/27 Due: 12/31/28

Organ Protective Effect of Cetirizine In Patients With Severe Burns

Phase: N/A Priority: Normal
NCT ID: NCT06126991 Org: User:
Start: 01/23/24 End: 12/31/25 Due: 12/31/26